These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3857219)

  • 1. Epirubicin in colorectal cancer. A phase II study of the early clinical trials group (EORTC).
    Holdener EE; Hansen HH; Høst H; Bruntsch U; Cavalli F; Renard J; Pinedo HM; Rozencweig M
    Invest New Drugs; 1985; 3(1):63-6. PubMed ID: 3857219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
    Michaelson R; Kemeny N; Young C
    Cancer Treat Rep; 1982 Sep; 66(9):1757-8. PubMed ID: 6956441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of 4'-epi-doxorubicin in metastatic colorectal carcinoma.
    Wils JA
    Invest New Drugs; 1984; 2(4):397-9. PubMed ID: 6595243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II evaluation of 4'epi-doxorubicin in patients with metastatic colorectal carcinoma.
    Ferrazzi E; Pappagallo GL; Nicoletto O; Fornasiero A; Refatti F; Cartei G; Vinante O; Fiorentino MV
    Tumori; 1984 Jun; 70(3):297-300. PubMed ID: 6588671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase-II clinical trial of 4'-epi-doxorubicin in advanced solid tumors.
    Martoni A; Giovannini M; Tomasi L; Camaggi CM; Bellanova B; Monetti N; Rossini G; Tarquinii M; Martini A; Pannuti F
    Cancer Chemother Pharmacol; 1984; 12(3):179-82. PubMed ID: 6584236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A phase I trial of 4'-epiadriamycin].
    Ogawa M; Ikeda K; Inagaki J; Horikoshi N; Inoue K; Nakada K; Usui N; Okada Y; Adachi K; Tada A
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):926-9. PubMed ID: 6586111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phase II study of epirubicin on breast cancer: a cooperative group study].
    Tominaga T; Kitamura M; Nomura Y; Abe O; Enomoto K; Ikeda T; Izuo M; Iino Y; Taguchi T; Tamura K
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2187-92. PubMed ID: 3459397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of acivicin in patients with advanced colorectal carcinoma.
    Adolphson CC; Ajani JA; Stroehlein JR; Barlogie B; Bodey GP; Korinek J; Bedikian AY
    Am J Clin Oncol; 1986 Jun; 9(3):189-91. PubMed ID: 3728371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of epirubicin in advanced squamous, adeno- and large cell carcinoma of the lung.
    Joss RA; Hansen HH; Hansen M; Renard J; Rozencweig M
    Eur J Cancer Clin Oncol; 1984 Apr; 20(4):495-9. PubMed ID: 6327315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of epirubicin in advanced malignant melanoma.
    Lopez M; Perno CF; Papaldo P; Di Lauro L; Ganzina F; Barduagni A
    Invest New Drugs; 1984; 2(3):315-7. PubMed ID: 6595241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of a 21-day continuous infusion schedule with epirubicin in metastatic colorectal cancer.
    Greidanus J; Willemse PH; Sleijfer DT; Mulder NH; Verschueren RC; Nieweg R; de Vries EG
    Eur J Cancer Clin Oncol; 1988 Apr; 24(4):801-2. PubMed ID: 3164271
    [No Abstract]   [Full Text] [Related]  

  • 12. [Phase II study of epirubicin on gastric cancer--a cooperative study of the Tokai Cancer Chemotherapy Group].
    Kimura K; Suga S; Kano H; Sakakibara K; Hayashi T; Nakai T; Nagano I; Yokoyama Y; Morise K; Hayakawa M
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2440-5. PubMed ID: 3460530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of esorubicin in patients with advanced colorectal carcinoma.
    Fiore J; Kemeny N; Raymond V; Young C
    Cancer Treat Rep; 1986 Oct; 70(10):1241-2. PubMed ID: 3530453
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II evaluation of 4'-epi-doxorubicin in patients with metastatic colorectal carcinoma.
    Ajani JA; Kanojia MD; Bodey GP
    Cancer Treat Rep; 1984 Dec; 68(12):1507-8. PubMed ID: 6595058
    [No Abstract]   [Full Text] [Related]  

  • 15. Epirubicin: a review of the pharmacology, clinical activity, and adverse effects of an adriamycin analogue.
    Cersosimo RJ; Hong WK
    J Clin Oncol; 1986 Mar; 4(3):425-39. PubMed ID: 3005521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phase II study of epirubicin in inoperable or recurrent gastric cancer].
    Sakata Y; Yoshida Y
    Gan To Kagaku Ryoho; 1986 May; 13(5):1887-92. PubMed ID: 3458431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II trial of 4'-epi-doxorubicin in advanced colorectal carcinoma: a Northern California Oncology Group study.
    Meyers FJ; Lewis B; Mitchell E; William L; Hannigan JF; Gribble M; Torti FM
    Cancer Treat Rep; 1985 Jan; 69(1):143-4. PubMed ID: 3855385
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study.
    Maroun JA; Fields AL; Pater JL; Stewart DJ; Cripps C; Eisenhauer E
    Cancer Treat Rep; 1984 Sep; 68(9):1121-3. PubMed ID: 6478451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer.
    Jain KK; Casper ES; Geller NL; Hakes TB; Kaufman RJ; Currie V; Schwartz W; Cassidy C; Petroni GR; Young CW
    J Clin Oncol; 1985 Jun; 3(6):818-26. PubMed ID: 3859587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A phase II study of epirubicin in malignant lymphoma].
    Masaoka T; Shibata H; Sampi K; Hirota Y; Yoshida Y; Chiba Y; Shirakawa S; Kobayashi T; Toki H; Tamura K
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2606-11. PubMed ID: 3461747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.